AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.2560
-0.1001 (-28.11%)
At close: Jun 4, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $4.11 million as of June 15, 2026. Its market cap has increased by 52.36% in one year.
Market Cap
4.11M
Enterprise Value
4.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.26
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 4.11M, a decrease of -79.85%. That is a compound annual growth rate of -31.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 4.11M | -68.53% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mosaic ImmunoEngineering | 4.88M |
| Orgenesis | 4.85M |
| America Great Health | 4.23M |
| GPL Holdings | 4.20M |
| Enzolytics | 3.86M |
| Bioxytran | 3.46M |
| Institute of Biomedical Research | 3.30M |
| Zenith Capital | 3.19M |